Form 4 Tracker
Immuneering Corp
IMRX

11 insider filings · Latest: Mar 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 16, 2026Jan 21 2:09 PMHarold Eugene BrakewoodChief Business Officer
Purchase
5,250$4.76$25.0K11,050(D)

View →

Jan 15, 2026Jan 20 2:17 PMThomas J. SchallDirector
Purchase
21,645$4.67$101.0K74,530(D)

View →

Jan 15, 2026Jan 16 9:07 PMBrett Matthew HallCHIEF SCIENTIFIC OFFICER
Purchase
2,298$4.57$10.5K376,496(D)

View →

Sep 23, 2025Sep 23 12:48 PMBERMAN ANN E
Proposed Sale
14,000$9.72$136.1K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 3, 2026Feb 5 1:44 PMMichael BookmanCHIEF LEGAL OFFICER, SECRETARY
Grant/Award
176,000$4.91176,000(D)

View →

Feb 3, 2026Feb 5 1:37 PMHarold Eugene BrakewoodChief Business Officer
Grant/Award
140,000$4.91140,000(D)

View →

Feb 3, 2026Feb 5 1:32 PMBrett Matthew HallCHIEF SCIENTIFIC OFFICER
Grant/Award
344,000$4.91344,000(D)

View →

Feb 3, 2026Feb 5 1:27 PMIgor MatushanskyChief Medical Officer
Grant/Award
140,000$4.91140,000(D)

View →

Feb 3, 2026Feb 5 1:22 PMMallory MoralesSVP Finance, CAO
Grant/Award
140,000$4.91140,000(D)

View →

Feb 3, 2026Feb 5 1:14 PMLeah R NeufeldCHIEF PEOPLE OFFICER
Grant/Award
140,000$4.91140,000(D)

View →

Feb 3, 2026Feb 5 1:10 PMZeskind Benjamin J.Director, PRESIDENT AND CEO
Grant/Award
688,000$4.91688,000(D)

View →